SCHISTOSOMAL MYELORADICULOPATHY IN A NON-ENDEMIC AREA

ABSTRACT Objective: To report a schistosomal myeloradiculopathy case in a non-endemic area. Case description: A previously healthy 11-year-old boy, stricken by an acute loss of strength on his lower limbs, followed by a loss of strength on his upper limbs and upper body, associated with altered se...

Full description

Bibliographic Details
Main Authors: Lívia Souza de Oliveira, Gabriela de Sio Puetter Kuzma, Luisa Carolina Vinhal Costa, Paulo Ramos David João
Format: Article
Language:English
Published: Sociedade de Pediatria de São Paulo 2020-01-01
Series:Revista Paulista de Pediatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822020000100604&tlng=pt
_version_ 1818339155559579648
author Lívia Souza de Oliveira
Gabriela de Sio Puetter Kuzma
Luisa Carolina Vinhal Costa
Paulo Ramos David João
author_facet Lívia Souza de Oliveira
Gabriela de Sio Puetter Kuzma
Luisa Carolina Vinhal Costa
Paulo Ramos David João
author_sort Lívia Souza de Oliveira
collection DOAJ
description ABSTRACT Objective: To report a schistosomal myeloradiculopathy case in a non-endemic area. Case description: A previously healthy 11-year-old boy, stricken by an acute loss of strength on his lower limbs, followed by a loss of strength on his upper limbs and upper body, associated with altered sensitivity of the vesical globe formation. The patient’s cerebrospinal fluid analysis showed eosinophilic meningitis, in addition to peripheral eosinophilia. The investigation resulted in a positive serology for Schistosoma mansoni. The treatment included steroids and praziquantel 60mg/kg, with a new dose after a month, as well as physical therapy for rehabilitation. The patient evolved with clinical improvement in the neurological exam, with a medullary section initially at C6, but now at T6. The patient is kept at prednisolone use (30mg/day) and longterm urinary catheter dependence. Comments: The schistosomiasis is endemic in many regions of Brazil; however, it has low incidence in the south of the country. Among its main manifestations, the schistosomal myeloradiculopathy is the most severe ectopic form of the disease, and should be suspected in patients with low back pain, strength and/or sensibility disorder of the lower limbs or urinary tract’s disturbance. Early diagnosis and treatment should be done in order to reduce severe neurological sequelae. Treatment includes schistosomiasis drugs, corticosteroids and/or surgery.
first_indexed 2024-12-13T15:22:31Z
format Article
id doaj.art-ae3a0bd9d4894d04b1c959b021e22748
institution Directory Open Access Journal
issn 1984-0462
language English
last_indexed 2024-12-13T15:22:31Z
publishDate 2020-01-01
publisher Sociedade de Pediatria de São Paulo
record_format Article
series Revista Paulista de Pediatria
spelling doaj.art-ae3a0bd9d4894d04b1c959b021e227482022-12-21T23:40:32ZengSociedade de Pediatria de São PauloRevista Paulista de Pediatria1984-04622020-01-013810.1590/1984-0462/2020/38/2018232SCHISTOSOMAL MYELORADICULOPATHY IN A NON-ENDEMIC AREALívia Souza de Oliveirahttps://orcid.org/0000-0003-2099-2927Gabriela de Sio Puetter Kuzmahttps://orcid.org/0000-0003-4287-4278Luisa Carolina Vinhal Costahttps://orcid.org/0000-0003-2949-4529Paulo Ramos David Joãohttps://orcid.org/0000-0002-2478-7886ABSTRACT Objective: To report a schistosomal myeloradiculopathy case in a non-endemic area. Case description: A previously healthy 11-year-old boy, stricken by an acute loss of strength on his lower limbs, followed by a loss of strength on his upper limbs and upper body, associated with altered sensitivity of the vesical globe formation. The patient’s cerebrospinal fluid analysis showed eosinophilic meningitis, in addition to peripheral eosinophilia. The investigation resulted in a positive serology for Schistosoma mansoni. The treatment included steroids and praziquantel 60mg/kg, with a new dose after a month, as well as physical therapy for rehabilitation. The patient evolved with clinical improvement in the neurological exam, with a medullary section initially at C6, but now at T6. The patient is kept at prednisolone use (30mg/day) and longterm urinary catheter dependence. Comments: The schistosomiasis is endemic in many regions of Brazil; however, it has low incidence in the south of the country. Among its main manifestations, the schistosomal myeloradiculopathy is the most severe ectopic form of the disease, and should be suspected in patients with low back pain, strength and/or sensibility disorder of the lower limbs or urinary tract’s disturbance. Early diagnosis and treatment should be done in order to reduce severe neurological sequelae. Treatment includes schistosomiasis drugs, corticosteroids and/or surgery.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822020000100604&tlng=ptSchistosomiasis mansoniNeuroschistosomiasisMyelitisAdolescent
spellingShingle Lívia Souza de Oliveira
Gabriela de Sio Puetter Kuzma
Luisa Carolina Vinhal Costa
Paulo Ramos David João
SCHISTOSOMAL MYELORADICULOPATHY IN A NON-ENDEMIC AREA
Revista Paulista de Pediatria
Schistosomiasis mansoni
Neuroschistosomiasis
Myelitis
Adolescent
title SCHISTOSOMAL MYELORADICULOPATHY IN A NON-ENDEMIC AREA
title_full SCHISTOSOMAL MYELORADICULOPATHY IN A NON-ENDEMIC AREA
title_fullStr SCHISTOSOMAL MYELORADICULOPATHY IN A NON-ENDEMIC AREA
title_full_unstemmed SCHISTOSOMAL MYELORADICULOPATHY IN A NON-ENDEMIC AREA
title_short SCHISTOSOMAL MYELORADICULOPATHY IN A NON-ENDEMIC AREA
title_sort schistosomal myeloradiculopathy in a non endemic area
topic Schistosomiasis mansoni
Neuroschistosomiasis
Myelitis
Adolescent
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822020000100604&tlng=pt
work_keys_str_mv AT liviasouzadeoliveira schistosomalmyeloradiculopathyinanonendemicarea
AT gabrieladesiopuetterkuzma schistosomalmyeloradiculopathyinanonendemicarea
AT luisacarolinavinhalcosta schistosomalmyeloradiculopathyinanonendemicarea
AT pauloramosdavidjoao schistosomalmyeloradiculopathyinanonendemicarea